Adma Biologics | ADMA - 税前利润

股票价格

11.26

每天变化

0.18 1.62%

每月一次

16.93%

每年

-48.49%

Q2 预测

11.02

金融业

USD

USD 624.24M

现金及等价物

USD 87.63M

USD 50.4M

USD 466.51M

USD 69.54M

USD 83.12M

USD 62.75M

USD 73.59M

624

EPS每股收益

USD 0.2

股本和储备

USD 477.32M

USD 88.82M

债务利息支出

USD 1.63M

USD 376K

USD 69.33M

USD 2.62B

USD 49.38M

USD 76.41M

USD 62.75M

普通股股本

USD 237.88M

29.73

USD 61.59M

USD 139.16M

销售和管理费用

USD 20.19M

USD 206.47M

贸易债权人

USD 22.52M

应收帐款人

USD 158.43M

	税前利润	更改		日
Adma Biologics	USD 61.59M		14.07M	2025-12
Alnylam Pharmaceuticals	USD 161.14M		77.83M	2025-12
BioCryst Pharmaceuticals	USD 248.02M		235.89M	2025-12
Minerva Neurosciences	USD 22.51M		30.74M	2024-09
Novavax	USD 17.9M		220.94M	2025-12
Omeros	USD -65.12M		21.27M	2024-06
Takeda	JPY 133.86B		105.69B	2025-12